Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Cefodizime

Home DrugsCefodizime

Experimental

Small Molecule

Cefodizime

Unknown Manufacturer

Cefodizime is a broad-spectrum, third-generation cephalosporin used to treat serious infections caused by susceptible bacteria.

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Overview

Cefodizime is a broad-spectrum, third-generation cephalosporin used to treat serious infections caused by susceptible bacteria.

Indications

临床用于敏感菌所致的下呼吸道、泌尿系感染。

Associated Conditions

1 associated conditions

Gram-Negative Bacterial Infections

Technical identifiers

Chemical Formula: C₂₀H₂₀N₆O₇S₄
CAS Number: 69739-16-8
UNII ID: Z31298J4HQ

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Intermediates for synthesis of cephalosporins and process for preparation of such intermediates
US 7452990 B2Applicant: LUPIN LTDPriority: 2002
US
2 publications
Preparation method of cefodizime acid
CN 108997378 AApplicant: SHANGHAI PHARMA XINYA PHARMACEUTICAL CO LTDPriority: 2018
CN
2 publications
Beta- lactamase suppressing antibacterial compound drugs
CN 1565457 AApplicant: ZHANG ZHEFENGPriority: 2003
CN
Organic amine salt of cephalosporin compound and its preparation method
CN 101007811 AApplicant: CHEN WENZHANPriority: 2007
CN
Method for preparing cefodizime sodium
CN 101239985 BApplicant: QILU ANTIBIOTICS PHARMACEUTICAL CO LTDPriority: 2008
CN
Amorphous cefodizime sodium and preparation method thereof and pharmaceutical composition comprising same
CN 101747345 BApplicant: SHENZHEN SALUBRIS PHARM CO LTDPriority: 2008
CN
Cefodizime sodium crystal form and preparation method thereof as well as drug compound comprising crystal form
CN 101759708 BApplicant: SHENZHEN SALUBRIS PHARM CO LTDPriority: 2008
CN
Method for synthesizing cefodizime sodium compound
CN 101486720 BApplicant: JUJUAN DENGPriority: 2009
CN
Cefodizime sodium proliposome preparation and preparation method thereof
CN 101584664 BApplicant: HAINAN SHUER PHARMACEUTICAL RES CO LTDPriority: 2009
CN
Cefodizime sodium hydrate, preparation method thereof and application thereof
CN 101830915 AApplicant: HU LIFANGPriority: 2010
CN

Page 1 of 4